Sareum (SAR) News Today → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free SAR Stock Alerts GBX 43.50 +3.00 (+7.41%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23, 2024 | americanbankingnews.comSareum (LON:SAR) Shares Up 21%May 2, 2024 | msn.comFed meeting, Amazon results, struggling US consumer - what's moving marketsApril 11, 2024 | lse.co.ukIssue of RiverFort Subscription SharesApril 4, 2024 | morningstar.comSareum Holdings PLC SARApril 4, 2024 | uk.investing.comSareum Holdings: A decisive period ahead for SDC-1801April 1, 2024 | msn.comTop 10 War Movies Based on Real Life You Can Watch on NetflixMarch 17, 2024 | lse.co.ukSareum Holdings touts new patent allowance for autoimmune therapyMarch 12, 2024 | lse.co.ukSareum shares slump on widened loss and funding talksFebruary 28, 2024 | finance.yahoo.comSareum Holdings plc (LON:SAR): Are Analysts Optimistic?February 19, 2024 | au.finance.yahoo.comSareum Holdings PLC (RYH0.SG)February 15, 2024 | lse.co.ukSareum hails safety profile for SDC-1801 after phase 1 trialJanuary 2, 2024 | lse.co.ukLONDON MARKET MIDDAY: London stocks make largely soft start to 2024January 2, 2024 | proactiveinvestors.com.auSareum surges as partner agrees licence for promising moleculeJanuary 2, 2024 | lse.co.ukSareum soars as partner agrees SRA737 licence with US biopharma firmDecember 14, 2023 | lse.co.ukEARNINGS AND TRADING: CleanTech raises GBP520,000 in open offerNovember 23, 2023 | fool.co.ukSareum shares just jumped 22%! Here’s whyNovember 9, 2023 | lse.co.ukEARNINGS AND TRADING: MetalNRG hails Gold Ridge findingsNovember 5, 2023 | msn.comThe 25 Best Sad Movies On Netflix That Will Give You All The FeelsNovember 3, 2023 | lse.co.ukSareum says patent notice in Japan boosts confidence in SDC-1801November 3, 2023 | marketwatch.comSareum Holdings Nears Patent for Autoimmune Disease Treatment in JapanOctober 13, 2023 | msn.comFTSE 100 Live: Jeremy Hunt warns on UK economy, Arm dips below IPO price, Next seals FatFace dealOctober 9, 2023 | lse.co.ukLONDON MARKET EARLY CALL: Higher call as high rate narrative settlesOctober 9, 2023 | lse.co.ukSareum says earnings down but product development going wellOctober 6, 2023 | lse.co.ukLONDON MARKET CLOSE: Stocks end higher, shaking off US nonfarms beatSeptember 5, 2023 | msn.comSareum doses first subjects in second stage of Phase 1a trial of SDC-1801September 4, 2023 | lse.co.ukSareum begins dosing participants in phase 1a trial for SDC-1801August 22, 2023 | msn.com25 Best Netflix Movies Based On True StoriesJuly 15, 2023 | msn.comNetflix: The thriller written by Angelina Jolie that is all the rage on the platform in the USJune 26, 2023 | lse.co.ukTRADING UPDATES: New patents for Sareum; Guanajuato hails assessmentJune 22, 2023 | marketwatch.comA thorough analysis of the Anaplastic Large Cell Lymphoma Treatment market Size with projected 13.7% CAGR growth from 2023 to 2030June 16, 2023 | ft.comFresh blow to City as WE Soda pulls $7.5bn London IPOMay 25, 2023 | finance.yahoo.comSAR.L - Sareum Holdings plcMay 18, 2023 | lse.co.ukTRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effectApril 27, 2023 | finance.yahoo.comWe're Not Very Worried About Sareum Holdings' (LON:SAR) Cash Burn RateApril 17, 2023 | marketwatch.comNON RECEPTOR TYROSINE PROTEIN KINASE TYK2 Market Size by 2031April 7, 2023 | marketwatch.comNon Receptor Tyrosine Protein Kinase TYK2 Market Demand by 2030March 30, 2023 | uk.news.yahoo.comShould I get invested in this FTSE pharma share?March 2, 2023 | marketwatch.comNew Market Report on Anaplastic Large Cell Lymphoma Comes With A Thorough Analysis Of Industry Trends, Share, Size.February 7, 2023 | finance.yahoo.comFollowing a 32% decline over last year, recent gains may please Sareum Holdings plc (LON:SAR) institutional ownersJanuary 23, 2023 | marketwatch.comNON RECEPTOR TYROSINE PROTEIN KINASE TYK2 Market Evolution Segmentation and Insight of Trends 2023 to 2028 with Top Countries DataOctober 25, 2022 | finance.yahoo.comSareum Holdings (LON:SAR) Is In A Good Position To Deliver On Growth PlansOctober 14, 2022 | msn.comSMALL CAP MOVERS: Property lender Lendinvest sinks 36% to a new low of 64p over risk of falling property prices; Cybersecurity firm Intercede surges 39% - msnNOWOctober 13, 2022 | lse.co.ukGlaxosmithkline News Headlines. GSK Share News. Financial News Articles for Gsk Plc Ord 31 1/4P updated throughout the day. - London South EastOctober 12, 2022 | marketscreener.comSareum Plunges 19% Amid GSK Unit's Plan To Return Cancer Medication Rights To CRT Pioneer Fund - Marketscreener.comOctober 12, 2022 | lse.co.ukNigeria's Forcados crude loadings to restart by end of October - SPDC | Financial News - London South EastOctober 12, 2022 | marketwatch.comSareum Holdings Says Sierra Oncology To Return Cancer Treatment License; Shares Fall - MarketWatchSeptember 13, 2022 | proactiveinvestors.com.auSmall Cap Feast - Critical Metals, Nightcap, Sareum Holdings, Spectra Systems, Altona Rare Earths and more... - Proactive Investors AustraliaSeptember 13, 2022 | morningstar.co.ukCORRECT: Sareum notes US FDA approval of Bristol-Myers's Sotyktu - MorningstarSeptember 12, 2022 | morningstar.co.ukSareum receives US US Food & Drug Administration approval for Sotyktu - MorningstarJuly 28, 2022 | globenewswire.comSareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update - GlobeNewswire Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. SAR Media Mentions By Week SAR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SAR News Sentiment▼0.000.77▲Average Medical News Sentiment SAR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SAR Articles This Week▼00▲SAR Articles Average Week Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Arix Bioscience News Today hVIVO News Today Avacta Group News Today Faron Pharmaceuticals Oy News Today Futura Medical News Today Scancell News Today Poolbeg Pharma News Today Redx Pharma News Today e-therapeutics News Today Arecor Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SAR) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
